EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RDS--CPAP or surfactant or both



RDS--CPAP or surfactant or both



Acta Paediatrica 101(464): 24-28



There is mounting evidence that early continuous positive airway pressure (CPAP) from birth is feasible and safe even in very preterm infants. However, many infants will develop respiratory distress syndrome (RDS) and require surfactant treatment. Combining a non-invasive ventilation approach with a strategy for surfactant administration is important, but questions remain about the optimal timing, mode of delivery and the value of predictive tests for surfactant deficiency. Early CPAP in very preterm infants is as safe as routine intubation in the delivery room. However, a strategy for surfactant administration should be part of a non-invasive ventilation approach for those infants at risk of developing significant RDS. .

(PDF emailed within 0-6 h: $19.90)

Accession: 055333996

Download citation: RISBibTeXText

PMID: 22404888

DOI: 10.1111/j.1651-2227.2011.02543.x



Related references

Changes in surfactant in ARDS. Effects of PEEP and CPAP on the biochemical composition of surfactant. Minerva Anestesiologica 51(1-2): 29-34, 1985

Combined unloading versus CPAP during spontaneous breathing in surfactant depleted cats Before and after surfactant replacement. Pediatric Research 42(3): 414, 1997

Fluctuating CPAP (F-CPAP) versus conventional CPAP (C-CPAP) in dogs with blood aspiration. Journal of Anesthesia 5(1): 36-42, 1991

A comparison of auto-adjusting CPAP, bilevel CPAP, and standard CPAP therapy in patients with REM related obstsructive sleep apnea. Neurology 60(5 Supplement 1): A40, March 11, 2003

Surfactant and nasal-CPAP before 30 weeks of gestation. Pediatric Research 42(3): 414, 1997

Surfactant therapy and nasal CPAP for newborns with RDS. Indian Pediatrics 32(4): 513-514, 1995

Surfactant therapy in infants managed with CPAP. Pediatric Research 33(4 PART 2): 314A, 1993

Surfactant administration in spontaneous breathing with N-CPAP for RDS. Acta Bio-Medica 85(1): 35-38, 2014

CPAP, Surfactant, or Both for the Preterm Infant: Resolving the Dilemma. JAMA Pediatrics 169(8): 715-717, 2015

Efficacy of surfactant therapy in infants managed with CPAP. Pediatric Pulmonology 20(3): 172-176, 1995

A Device For Nebulizing Surfactant During CPAP Treatment In Neonates. Pediatric Research 37(4 PART 2): 325A, 1994

Prematures greater than 31 weeks with HMD can be managed with CPAP after rescue surfactant. Journal of Investigative Medicine 43(SUPPL 1): 18A, 1995

Use of CPAP and surfactant therapy in newborns with respiratory distress syndrome. Indian Journal of Pediatrics 81(5): 481-488, 2015

Early CPAP versus surfactant in extremely preterm infants. New England Journal of Medicine 362(21): 1970-1979, 2010